Patricia LoRusso, DO
Amy and Joseph Perella Professor of Medicine (Medical Oncology)Cards
About
Research
Overview
LoRusso has served as co-chair of the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP) Investigational Drug Steering Committee. She also served on the scientific committee of the American Association for Cancer Research (AACR), the education and scientific committees of the American Society of Clinical Oncology (ASCO), numerous peer-reviewed study sections, and NCI committees. She has garnered numerous awards, including the 1999 Heroes of Breast Cancer Award; 2004 Bennett J. Cohen Educational Leadership Award for Medical Research, 2008 NCI Michaele C. Christian Oncology Development Lectureship and Award; the 2014 Targeted Anticancer Therapies (TAT) Honorary Award; and will receive the 2014 Michigan State University Distinguished Alumni Award. She was recently honored as one of the 2014 Massachusetts General Hospital Cancer Center’s “One Hundred” individuals and organizations recognized for their dedication in making a difference in the fight against cancer. LoRusso is a former editor of Investigational New Drugs, is currently on the editorial board for Clinical Cancer Research, and is a reviewer for several journals. She has authored more than 200 articles on cancer research in peer-reviewed journals, and written multiple book chapters.
Interventional oncology; Liver cancer
Medical Research Interests
Academic Achievements & Community Involvement
Clinical Care
Overview
Oncologist Patricia LoRusso, DO, associate director of innovative medicine at Yale Medicine, has expertise in testing new treatments on patient volunteers who have advanced stages of cancer. Her passion is bringing research breakthroughs into the clinic to help patients with different types and stages of cancer.
The clinical trials at Yale Cancer Center offer access to experimental drugs that are sometimes a patient’s last and best hope, says Dr. LoRusso. Therapies that prove successful can advance through the U.S. Food and Drug Administration approval process. “Many of the drugs tested here will help generations of cancer patients,” says Dr. LoRusso. In her career, 14 cancer drugs she has performed clinical trials on, which she refers to as her “children,” have gone on to gain FDA approval.
Dr. LoRusso leads the Phase I clinical trials infusion center at Smilow Cancer Hospital at Yale New Haven. She infuses the center with a warm, team-focused approach that puts patients at the center of care. “We’re improving patients’ lives in Connecticut and beyond,” says Dr. LoRusso.
Clinical Specialties
Fact Sheets
Clinical Trials
Learn More on Yale MedicinePediatric Chemotherapy
Learn More on Yale MedicineBreast Cancer
Learn More on Yale MedicineCancer
Learn More on Yale Medicine
Board Certifications
Medical Oncology
- Certification Organization
- American Osteopathic Board of Internal Medicine
- Original Certification Date
- 1991
Internal Medicine
- Certification Organization
- American Osteopathic Board of Internal Medicine
- Original Certification Date
- 1987
Yale Medicine News
News
News
- November 26, 2024
Advancing Breast Cancer Research: Yale Cancer Center to Share Insights at International Conference
- September 18, 2024Source: CBS Philadelphia
HealthWatch Experts warn of an alarming trend of new cancer cases among young adults
- September 18, 2024Source: AACR
Dr. Patricia M. LoRusso: Envisioning the Future of Cancer Science and Medicine
- June 12, 2024Source: Yale New Haven Health
Yale New Haven Health and Yale University celebrate Innovation Awards